Oculis
Nicola Parr is an experienced professional in the field of Quality Assurance, currently serving as the Director of Quality Assurance - CRO at Oculis since April 2025. Prior roles include Audit & CAPA Lead at Debiopharm, CSV Audit Lead and Associate Director at Galapagos, and Senior Manager Digital QA at GW Pharmaceuticals plc. Additionally, Nicola has held various positions at Johnson & Johnson, Worldwide Clinical Trials, Perceptive Informatics, and ClinPhone, developing a robust background in auditing, digital quality assurance, and project management. Academic achievements include studies at The Open University from 2002 to 2004.
This person is not in any teams
This person is not in any offices
Oculis
1 followers
Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back-and front-of-the-eye in order to improve the sight and the lives of patients worldwide.